Published in J Neurochem on May 01, 1991
Axon degeneration: molecular mechanisms of a self-destruction pathway. J Cell Biol (2012) 2.26
Nicotinamide restores cognition in Alzheimer's disease transgenic mice via a mechanism involving sirtuin inhibition and selective reduction of Thr231-phosphotau. J Neurosci (2008) 1.88
Inhibition of calpains improves memory and synaptic transmission in a mouse model of Alzheimer disease. J Clin Invest (2008) 1.79
Activation of m-calpain (calpain II) by epidermal growth factor is limited by protein kinase A phosphorylation of m-calpain. Mol Cell Biol (2002) 1.64
Calpain inhibitor AK295 attenuates motor and cognitive deficits following experimental brain injury in the rat. Proc Natl Acad Sci U S A (1996) 1.15
Mechanical membrane injury induces axonal beading through localized activation of calpain. Exp Neurol (2009) 1.04
Wallerian-like degeneration of central neurons after synchronized and geometrically registered mass axotomy in a three-compartmental microfluidic chip. Neurotox Res (2010) 1.00
Is the amyloid hypothesis of Alzheimer's disease therapeutically relevant? Biochem J (2012) 0.97
Effect of antenatal betamethasone treatment on microtubule-associated proteins MAP1B and MAP2 in fetal sheep. J Physiol (2001) 0.95
Unique function of Kinesin Kif5A in localization of mitochondria in axons. J Neurosci (2014) 0.91
Induction of growth cone formation by transient and localized increases of intracellular proteolytic activity. J Cell Biol (1998) 0.89
Neuroprotective mechanism of taurine due to up-regulating calpastatin and down-regulating calpain and caspase-3 during focal cerebral ischemia. Cell Mol Neurobiol (2007) 0.89
Targeting calpain in synaptic plasticity. Expert Opin Ther Targets (2013) 0.85
Cross-talk between calpain and caspase-3 in penumbra and core during focal cerebral ischemia-reperfusion. Cell Mol Neurobiol (2007) 0.85
Affinity labelling of the Ca(2+)-activated neutral proteinase (calpain) in intact human platelets. Biochem J (1993) 0.81
An immunocytochemical study of calpain II in the hippocampus of rats injected with kainate. Exp Brain Res (1997) 0.75
The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling. Prog Neurobiol (2001) 6.12
Ectopically expressed CAG repeats cause intranuclear inclusions and a progressive late onset neurological phenotype in the mouse. Cell (1997) 2.13
CREB DNA binding activity is inhibited by glycogen synthase kinase-3 beta and facilitated by lithium. J Neurochem (2001) 2.11
Glycogen synthase kinase-3beta facilitates staurosporine- and heat shock-induced apoptosis. Protection by lithium. J Biol Chem (2000) 1.98
Proapoptotic stimuli induce nuclear accumulation of glycogen synthase kinase-3 beta. J Biol Chem (2001) 1.90
Inhibition of glycogen synthase kinase-3 is necessary for the rapid antidepressant effect of ketamine in mice. Mol Psychiatry (2011) 1.86
Bisindolylmaleimide VIII facilitates Fas-mediated apoptosis and inhibits T cell-mediated autoimmune diseases. Nat Med (1999) 1.73
Detection of phosphorylated Ser262 in fetal tau, adult tau, and paired helical filament tau. J Biol Chem (1995) 1.70
Insulin transiently increases tau phosphorylation: involvement of glycogen synthase kinase-3beta and Fyn tyrosine kinase. J Neurochem (1999) 1.52
Identification of an antiapoptotic protein complex at death receptors. Cell Death Differ (2008) 1.46
Caspase-3 activation induced by inhibition of mitochondrial complex I is facilitated by glycogen synthase kinase-3beta and attenuated by lithium. Brain Res (2001) 1.30
Opposing actions of phosphatidylinositol 3-kinase and glycogen synthase kinase-3beta in the regulation of HSF-1 activity. J Neurochem (2000) 1.26
The role of microtubule-associated protein 2 (MAP-2) in neuronal growth, plasticity, and degeneration. J Neurosci Res (1992) 1.17
High affinity choline transport and acetylCoA production in brain and their roles in the regulation of acetylcholine synthesis. Brain Res (1979) 1.16
Biochemical effects of phosphatidylcholine treatment in rats. Biochem Pharmacol (1984) 1.08
Proteolysis of tau by calpain. Biochem Biophys Res Commun (1989) 1.04
Choline accumulates in erythrocytes during lithium therapy. N Engl J Med (1978) 1.03
Defective expression of hematopoietic cell protein tyrosine phosphatase (HCP) in lymphoid cells blocks Fas-mediated apoptosis. Immunity (1995) 1.03
Glycogen synthase kinase-3beta, beta-catenin, and tau in postmortem bipolar brain. J Neural Transm (Vienna) (1999) 1.00
Effects of drugs on the initiation and maintenance of status epilepticus induced by administration of pilocarpine to lithium-pretreated rats. Exp Neurol (1987) 0.97
Anticonvulsant actions of MK-801 on the lithium-pilocarpine model of status epilepticus in rats. Exp Neurol (1989) 0.94
Oxidative stress and heat shock stimulate RGS2 expression in 1321N1 astrocytoma cells. Arch Biochem Biophys (2001) 0.92
Phosphoinositide signaling in human brain. Prog Neurobiol (1996) 0.92
Muscarinic receptor stimulation increases regulators of G-protein signaling 2 mRNA levels through a protein kinase C-dependent mechanism. J Biol Chem (1999) 0.91
Oxidative stress differentially modulates phosphorylation of ERK, p38 and CREB induced by NGF or EGF in PC12 cells. Neurobiol Aging (2000) 0.91
Effects of postmortem interval, age, and Alzheimer's disease on G-proteins in human brain. Neurobiol Aging (1996) 0.91
Characterization of lithium potentiation of pilocarpine-induced status epilepticus in rats. Exp Neurol (1986) 0.90
Glycogen synthase kinase-3 regulates inflammatory tolerance in astrocytes. Neuroscience (2010) 0.90
Disruption of circadian rhythmicity and suprachiasmatic action potential frequency in a mouse model with constitutive activation of glycogen synthase kinase 3. Neuroscience (2012) 0.90
Lithium treatment alleviates impaired cognition in a mouse model of fragile X syndrome. Genes Brain Behav (2013) 0.88
Alterations in phosphoinositide signaling and G-protein levels in depressed suicide brain. Brain Res (1996) 0.88
Cholinergic stimulation of AP-1 and NF kappa B transcription factors is differentially sensitive to oxidative stress in SH-SY5Y neuroblastoma: relationship to phosphoinositide hydrolysis. J Neurosci (1996) 0.88
Peroxynitrite modulates tyrosine phosphorylation and phosphoinositide signalling in human neuroblastoma SH-SY5Y cells: attenuated effects in human 1321N1 astrocytoma cells. Biochem J (1998) 0.87
Muscarinic M3 and epidermal growth factor receptors activate mutually inhibitory signaling cascades in human neuroblastoma SH-SY5Y cells. Biochem Biophys Res Commun (1999) 0.87
Lithium attenuates p53 levels in human neuroblastoma SH-SY5Y cells. Neuroreport (1999) 0.86
Novel bimodal effects of the G-protein tissue transglutaminase on adrenoreceptor signalling. Biochem J (1999) 0.86
Pertussis toxin-sensitive G protein alpha-subunits: production of monoclonal antibodies and detection of differential increases on differentiation of PC12 and LA-N-5 cells. J Neurochem (1995) 0.86
Metabolic effects of nicotinamide administration in rats. J Nutr (1983) 0.86
Erythrocyte choline concentrations are elevated in manic patients. Proc Natl Acad Sci U S A (1980) 0.86
The interrelationship between selective tau phosphorylation and microtubule association. Brain Res (1998) 0.86
Inhibition of NFkB DNA binding activity by glucocorticoids in rat brain. Neurosci Lett (1995) 0.85
Further evidence for a muscarinic component to the neural vasodilator innervation of cerebral and cranial extracerebral arteries of the cat. Circ Res (1982) 0.85
Aluminum impairs glucose utilization and cholinergic activity in rat brain in vitro. Toxicology (1986) 0.84
Acetylcholine content in rat brain is elevated by status epilepticus induced by lithium and pilocarpine. J Neurochem (1987) 0.84
Second messengers regulate RGS2 expression which is targeted to the nucleus. Biochim Biophys Acta (2001) 0.84
RGS2: regulation of expression and nuclear localization. Biochem Biophys Res Commun (2001) 0.84
A mechanism for the accumulation of choline in erythrocytes during treatment with lithium. Commun Psychopharmacol (1980) 0.84
Regulation of acetylcholine synthesis: does cytoplasmic acetylcholine control high affinity choline uptake? Science (1976) 0.84
G-proteins modulate amiloride-sensitive sodium channels. J Biol Chem (1994) 0.83
Cholinergic stimulation of early growth response-1 DNA binding activity requires protein kinase C and mitogen-activated protein kinase kinase activation and is inhibited by sodium valproate in SH-SY5Y cells. J Neurochem (1999) 0.83
Acetylcholine turnover and compartmentation in rat brain synaptosomes. J Neurochem (1981) 0.83
Dexamethasone attenuates NF-kappa B DNA binding activity without inducing I kappa B levels in rat brain in vivo. Brain Res Mol Brain Res (1997) 0.83
Synaptosomal transport and acetylation of choline. Life Sci (1977) 0.82
Choline and phospholipid metabolism and the synthesis of acetylcholine in rat brain. J Neurosci Res (1979) 0.82
Comparison of [3H]phosphatidylinositol and [3H]phosphatidylinositol 4,5-bisphosphate hydrolysis in postmortem human brain membranes and characterization of stimulation by dopamine D1 receptors. J Neurochem (1997) 0.82
Brain amino acid concentrations in rats killed by decapitation and microwave irradiation. J Neurosci Methods (1990) 0.82
Phosphorylation of rat brain cytoskeletal proteins is increased after orally administered aluminum. Brain Res (1988) 0.82
Modulation by inositol of cholinergic- and serotonergic-induced seizures in lithium-treated rats. Brain Res (1995) 0.81
Quinacrine and 2-(4-phenylpiperidino)cyclohexanol (AH5183) inhibit acetylcholine release and synthesis in rat brain slices. Mol Pharmacol (1986) 0.81
Oral aluminum alters in vitro protein phosphorylation and kinase activities in rat brain. Neurobiol Aging (1990) 0.81
Status epilepticus is produced by administration of cholinergic agonists to lithium-treated rats: comparison with kainic acid. Exp Neurol (1987) 0.81
Phosphoinositide hydrolysis, G alpha q, phospholipase C, and protein kinase C in post mortem human brain: effects of post mortem interval, subject age, and Alzheimer's disease. Neuroscience (1995) 0.81
Rapid activation of heat shock factor-1 DNA binding by H2O2 and modulation by glutathione in human neuroblastoma and Alzheimer's disease cybrid cells. Brain Res Mol Brain Res (1999) 0.81
Modulation of endogenous ADP-ribosylation in rat brain. Brain Res (1992) 0.81
Analysis of the convulsant-potentiating effects of lithium in rats. Exp Neurol (1991) 0.80
Determination of inositol phosphates and other anions in rat brain. J Chromatogr Sci (1989) 0.80
Effect of pretreatment under various cationic conditions on acetylcholine content and choline transport in rat whole brain synaptosomes. J Neurochem (1978) 0.80
Diurnal variation in kainate-induced AP-1 activation in rat brain: influence of glucocorticoids. Brain Res Mol Brain Res (1995) 0.80
Chronic lithium treatment impairs phosphatidylinositol hydrolysis in membranes from rat brain regions. J Neurochem (1992) 0.80
Regulation of acetylcholine synthesis: control of choline transport and acetylation in synaptosomes. J Neurochem (1978) 0.80
Neurochemical consequences of status epilepticus induced in rats by coadministration of lithium and pilocarpine. Exp Neurol (1986) 0.80
Reduced Ca2+ flux in synaptosomes from cats with GM1 gangliosidosis. Brain Res (1987) 0.80
Proteolysis of microtubule-associated protein 2 and tubulin by cathepsin D. J Neurochem (1991) 0.79
Dietary aluminum selectively decreases MAP-2 in brains of developing and adult rats. Neurotoxicology (1992) 0.79
Distinctive rat brain immediate early gene responses to seizures induced by lithium plus pilocarpine. Brain Res Mol Brain Res (1994) 0.79
The utilization of choline and acetyl coenzyme A for the synthesis of acetylcholine. J Neurochem (1980) 0.79
Aluminum inhibits the fast phase of voltage-dependent calcium influx into synaptosomes. J Neurochem (1987) 0.79
Biological and neuropsychological characterization of physostigmine responders and nonresponders in Alzheimer's disease. J Am Geriatr Soc (1990) 0.78
Selective inhibition of the expression of signal transduction proteins by lithium in nerve growth factor-differentiated PC12 cells. J Neurochem (1995) 0.78
Effects of chronic lithium treatment on protein kinase C and cyclic AMP-dependent protein phosphorylation. Biol Psychiatry (1991) 0.78
Brain G-protein proteolysis by calpain: enhancement by lithium. Brain Res (1994) 0.78
Modulation of carbachol-stimulated inositol phospholipid hydrolysis in rat cerebral cortex. Neurochem Res (1987) 0.78
Alterations in muscarinic receptor-coupled phosphoinositide hydrolysis and AP-1 activation in Alzheimer's disease cybrid cells. Neurobiol Aging (2000) 0.78
Dimethylaminoethanol (deanol) metabolism in rat brain and its effect on acetylcholine synthesis. J Pharmacol Exp Ther (1979) 0.77
Src family kinase involvement in muscarinic receptor-induced tyrosine phosphorylation in differentiated SH-SY5Y cells. Neurochem Res (2001) 0.77
Increased metabolism of acetylcholine in brain of cats with Gm1 gangliosidosis. Brain Res (1985) 0.77
Cholinergic processes in blood samples from patients with major psychiatric disorders. Biol Psychiatry (1985) 0.77
Cholinergic- and stress-induced signaling activities in cells overexpressing wild-type and mutant presenilin-1. Brain Res (2001) 0.77
Effects of phosphatidylcholine administration to rats on choline in blood and choline and acetylcholine in brain. J Pharmacol Exp Ther (1982) 0.77
Formation of triple-stranded bovine DNA in vitro. Nature (1975) 0.77
Pertussis toxin potentiates seizures induced by pilocarpine, kainic acid and N-methyl-D-aspartate. Brain Res (1991) 0.77
Protein synthesis inhibitors attenuate seizures induced in rats by lithium plus pilocarpine. Exp Neurol (1994) 0.76
Increased acetylcholine synthesis and release in brains of cats with GM1 gangliosidosis. J Neurochem (1986) 0.76
Free and bound choline blood levels after phosphatidylcholine. Clin Pharmacol Ther (1982) 0.76
Dexamethasone attenuates kainate-induced AP-1 activation in rat brain. Brain Res Mol Brain Res (1994) 0.76
Aluminum alters cyclic AMP and cyclic GMP levels but not presynaptic cholinergic markers in rat brain in vivo. Brain Res (1987) 0.76
Chronic lithium treatment reduces norepinephrine-stimulated inositol phospholipid hydrolysis in rat cortex. Eur J Pharmacol (1987) 0.76
Alpha-1 adrenergic receptor binding and adrenergic-stimulated cyclic AMP production in rat cerebral cortex after chronic lithium treatment. J Neural Transm Gen Sect (1990) 0.75
Circadian variation in rat brain AP-1 DNA binding activity after cholinergic stimulation: modulation by lithium. Psychopharmacology (Berl) (1995) 0.75